Remibrutinib: A Novel BTKi in Development for MS With a Favorable Safety Profile in Various Autoimmune Disorders (P7-3.015)
Williams M, Airas L, Chitnis T, Saini S, Hide M, Sussman G, Nakahara J, Bermel R, Dörner T, Loop B, Ziehn M, Willi R, Kieseier B, Nikolaev I, Haemmerle S, Zharkov A, Siegel R, Cenni B, Wiendl H, Maurer M, Giménez-Arnau A, Montalban X. Remibrutinib: A Novel BTKi in Development for MS With a Favorable Safety Profile in Various Autoimmune Disorders (P7-3.015). Neurology 2023, 100 DOI: 10.1212/wnl.0000000000202933.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply